Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cohn

Showing results (451-460 of 612) with videos related to

Pageof 62
Sort By:
Cancer Chemotherapy and Pharmacology|January 2, 2010
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumorsElizabeth Fox, John M Maris, Susan L Cohn, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signatureMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Health Security|August 22, 2019
Real-time Epidemic Forecasting: Challenges and OpportunitiesAngel N Desai, Moritz U G Kraemer, Sangeeta Bhatia, et al.
The New England Journal of Medicine|July 5, 1990
Effects of human growth hormone in men over 60 years oldD Rudman, A G Feller, H S Nagraj, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastomaX X Tang, H Zhao, M E Robinson, et al.
Plos One|September 28, 2011
Secreted protein acidic and rich in cysteine is a matrix scavenger chaperoneAlexandre Chlenski, Lisa J Guerrero, Helen R Salwen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk StratificationHannah G Bender, Meredith S Irwin, Michael D Hogarty, et al.
Oncogene|December 1, 1990
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplificationS L Cohn, H Salwen, M W Quasney, et al.
Clinical and Translational Science|February 22, 2026
Hypoxia Promotes an Adrenergic to Mesenchymal Transcriptional Program Transition in NeuroblastomaGepoliano S Chaves, Mohansrinivas Chennakesavalu, Kelley Moore, et al.
Neoplasia (New York, N.Y.)|June 23, 2001
Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group studyP Mathew, M B Valentine, L C Bowman, et al.
Pageof 62

Showing results (451-460 of 612) with videos related to

Sort By:
Pageof 62
Cancer Chemotherapy and Pharmacology|January 2, 2010
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumorsElizabeth Fox, John M Maris, Susan L Cohn, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signatureMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Health Security|August 22, 2019
Real-time Epidemic Forecasting: Challenges and OpportunitiesAngel N Desai, Moritz U G Kraemer, Sangeeta Bhatia, et al.
The New England Journal of Medicine|July 5, 1990
Effects of human growth hormone in men over 60 years oldD Rudman, A G Feller, H S Nagraj, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastomaX X Tang, H Zhao, M E Robinson, et al.
Plos One|September 28, 2011
Secreted protein acidic and rich in cysteine is a matrix scavenger chaperoneAlexandre Chlenski, Lisa J Guerrero, Helen R Salwen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk StratificationHannah G Bender, Meredith S Irwin, Michael D Hogarty, et al.
Oncogene|December 1, 1990
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplificationS L Cohn, H Salwen, M W Quasney, et al.
Clinical and Translational Science|February 22, 2026
Hypoxia Promotes an Adrenergic to Mesenchymal Transcriptional Program Transition in NeuroblastomaGepoliano S Chaves, Mohansrinivas Chennakesavalu, Kelley Moore, et al.
Neoplasia (New York, N.Y.)|June 23, 2001
Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group studyP Mathew, M B Valentine, L C Bowman, et al.
Pageof 62